8-K: Healthcare Realty Posts Q4 Profit, Launches $600M CP Program

Healthcare Realty Trust reported a GAAP net income of $0.04 per share for Q4 2025 and introduced 2026 guidance, alongside establishing a new $600 million commercial paper program.

Summary

• Achieved GAAP Net Income of $0.04 per share for the fourth quarter ended December 31, 2025, a significant improvement from prior quarters.
• Reported a full year 2025 GAAP Net Loss of $(0.71) per share.
• Normalized FFO was $0.40 per share for Q4 2025 and $1.61 per share for the full year 2025.
• Funds Available for Distribution (FAD) reached $113.9 million for Q4 2025 (75% payout ratio) and $448.3 million for full year 2025 (87% payout ratio).
• Delivered strong same-store cash NOI growth of +5.5% in Q4 2025 and +4.8% for the full year 2025, exceeding historical levels.
• Tenant retention stood at 82.7% in Q4 2025 and 81.5% for the full year 2025, with cash leasing spreads of +3.7% and +3.1% respectively.
• Executed 1.5 million square feet of new and renewal leases in Q4 2025, including 316,000 square feet of new leases, and approximately 5.8 million square feet for the full year 2025.
• Completed $682 million in asset sales during Q4 2025 and through February 2026, contributing to a total of $1.2 billion in asset sales during 2025 and through February 2026 at a blended cap rate of 6.7%.
• Reduced Net Debt to Adjusted EBITDA to 5.4x at December 31, 2025, down from 6.1x at the prior year-end.
• Moody's Investors Service revised its outlook to Stable and affirmed a Baa2 credit rating in December 2025.
• Established an inaugural commercial paper program allowing the issuance of up to $600 million of short-term, unsecured commercial paper notes.
• Repaid approximately $650 million of term loans and $250 million of senior notes, and extended a $1.5 billion revolver to mature in July 2030.
• Reduced run-rate General & Administrative (G&A) expense by $10 million through cost-saving implementations.
• Declared a common stock dividend of $0.24 per share for Q4 2025, payable on March 11, 2026, to stockholders of record on February 24, 2026.
• Introduced full year 2026 guidance, projecting GAAP Net Loss per share between $(0.05) and $0.05, NAREIT FFO per share between $1.44 and $1.50, and Same Store Cash NOI growth between 3.5% and 4.5%.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, highlighting significant operational improvements, successful debt reduction, and strategic portfolio refinement, despite the full-year GAAP loss. The strong Q4 performance and positive credit outlook revision are encouraging.

Positives

• Achieved GAAP Net Income of $0.04 per share in Q4 2025, marking a positive shift from previous quarterly losses.
• Delivered strong same-store cash NOI growth of +5.5% in Q4 2025 and +4.8% for the full year 2025, surpassing historical levels.
• Successfully completed $1.2 billion in asset dispositions during 2025 and early 2026 at an attractive blended cap rate of 6.7%, strengthening the balance sheet.
• Improved leverage by reducing Net Debt to Adjusted EBITDA to 5.4x from 6.1x at the prior year-end.
• Moody's Investors Service revised its credit outlook to Stable and affirmed a Baa2 credit rating, reflecting enhanced financial stability.
• Established a new $600 million commercial paper program, diversifying financing alternatives and enhancing liquidity.
• Repaid substantial debt, including $650 million of term loans and $250 million of senior notes, and extended the $1.5 billion revolver maturity to July 2030.
• Implemented cost-saving measures resulting in a $10 million reduction in run-rate G&A expense.
• Demonstrated significant leasing momentum with 1.5 million square feet executed in Q4 2025 and nearly 1 million square feet year-to-date in early 2026.
• Achieved a sequential lease-up of over 500 basis points in redevelopment projects, indicating successful project execution.
• Strengthened corporate governance and leadership team with experienced industry executives, positioning the company for sustainable long-term growth.

Negatives

• Reported a full year 2025 GAAP Net Loss of $(0.71) per share, indicating overall unprofitability for the year despite a strong Q4.
• The 2026 guidance for GAAP Net Loss per share ranges from $(0.05) to $0.05, suggesting continued unprofitability or a break-even scenario at best for the upcoming year.
• The low end of the 2026 Normalized FFO per share guidance ($1.58) is slightly below the full year 2025 actual ($1.61).
• The 2026 Same Store Cash NOI growth guidance (3.5%-4.5%) is lower than the 2025 actual growth of 4.8%.
• Incurred significant impairment charges on real estate assets and credit loss reserves totaling $(105.8) million in Q4 2025 and $(246.0) million for the full year 2025.
• Rental income decreased from $300.065 million in Q4 2024 to $274.731 million in Q4 2025, likely due to asset dispositions.

Risks

• Expected results may not be achieved.
• Uncertainty of expected future financial performance and results.
• Pandemics or other health crises.
• Increases in interest rates.
• Availability and cost of capital at expected rates.
• Competition for quality assets.
• Negative developments in the operating results or financial condition of tenants, including their ability to pay rent.
• Ability to reposition or sell facilities with profitable results.
• Ability to release space at similar rates as vacancies occur.
• Ability to renew expiring leases.
• Government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements.
• Unanticipated difficulties and/or expenditures relating to future acquisitions and developments.
• Changes in rules or practices governing financial reporting.
• May be required under purchase options to sell properties and may not be able to reinvest proceeds from such sales at rates of return equal to the return received on the properties sold.
• Uninsured or underinsured losses related to casualty or liability.
• Incurrence of impairment charges on real estate properties or other assets.
• Other legal and operational matters.

Future Outlook

For 2026, Healthcare Realty Trust projects GAAP Net Loss per share between $(0.05) and $0.05, NAREIT FFO per share between $1.44 and $1.50, Normalized FFO per share between $1.58 and $1.64, and Same Store Cash NOI growth between 3.5% and 4.5%. The guidance reflects current and future market conditions, including assumptions on rental rates, occupancy, interest rates, and operating and general and administrative expenses. The company's guidance does not contemplate impacts from gains or losses from dispositions, potential impairments, or debt extinguishment costs, nor does it include any future acquisitions, developments, or share issuances or repurchases, other than as discussed in the detailed guidance assumptions.

Management Comments

• "2025 represented a transformational year for Healthcare Realty. Our operational team delivered same-store growth that continues to exceed historical levels while our transactions team exceeded targets with $1.2 billion in dispositions at attractive pricing levels." Peter Scott, President and Chief Executive Officer.
• "We are encouraged by secular long-term trends driving demand for outpatient medical services, tenant space and assets across the country." Peter Scott, President and Chief Executive Officer.
• "We have strategically strengthened our corporate governance, leadership team and balance sheet over the past nine months, and I would like to thank the entire Healthcare Realty team for their strong efforts as we position the Company for sustainable long-term growth." Peter Scott, President and Chief Executive Officer.

Industry Context

StockSavvy.ai notes that Healthcare Realty Trust's focus on medical outpatient buildings aligns with broader industry trends favoring outpatient care delivery, driven by technological advancements and cost efficiencies. The company's strategic dispositions and debt reduction efforts position it to navigate a potentially challenging interest rate environment more effectively than peers with higher leverage. The strong same-store NOI growth suggests robust demand for well-located medical office space, a positive indicator for the specialized REIT sector.

Comparison to Industry Standards

• StockSavvy.ai observes that Healthcare Realty's full year 2025 same-store cash NOI growth of +4.8% is competitive within the healthcare REIT sector, often exceeding the average for medical office building (MOB) portfolios which typically range from 2.5% to 4.0%.
• The reduction in Net Debt to Adjusted EBITDA from 6.1x to 5.4x demonstrates a stronger balance sheet compared to some highly leveraged peers in the broader REIT market, moving closer to the industry's preferred range of 5.0x or below for investment-grade ratings.
• The 6.7% blended cap rate on $1.2 billion in dispositions indicates successful asset recycling at valuations that are generally considered attractive in the current market, especially when compared to recent transaction cap rates for similar MOB assets which have seen some expansion.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Positive impact from Q4 profitability, dividend declaration, share repurchases, improved credit rating, and strategic positioning for long-term growth. Potential dilution from future bond issuance.
• Creditors: Positive impact from significant debt reduction, extended revolver maturity, diversified financing through commercial paper program, and improved credit outlook.
• Tenants: Continued strong tenant retention and leasing spreads indicate stable relationships and demand for properties.
• Employees: Management changes and cost-saving implementations could imply some restructuring, but overall efforts are aimed at sustainable growth.

Next Steps

• A conference call is scheduled for Friday, February 13, 2026, at 9:00 a.m. Eastern Time, to discuss earnings results, quarterly activities, general operations, and industry trends.
• A common stock dividend of $0.24 per share will be paid on March 11, 2026, to Class A common stockholders of record on February 24, 2026.
• One asset sale transaction is expected to close later in February 2026.
• A $45 million loan at a 6.5% interest rate is expected to be repaid at maturity in March 2026.
• The company assumes a mid-year bond issuance of $600 million at an approximate 5% interest rate as part of its 2026 guidance.

Key Dates

Recommendation

The company demonstrated strong operational improvements in Q4 2025, including positive GAAP net income, robust same-store NOI growth, and significant debt reduction, which led to a credit outlook upgrade. The establishment of a commercial paper program diversifies financing. However, the full-year 2025 still reflects a net loss, and 2026 guidance for FFO and same-store NOI growth is slightly tempered compared to 2025 actuals. While the strategic transformation is positive, the forward guidance suggests a period of stabilization rather than aggressive growth, warranting a 'hold' as the market assesses the sustainability of these improvements and the company's ability to return to consistent profitability.

Keywords

Healthcare Realty Trust, HR, REIT, Medical Office Buildings, MOB, Real Estate Investment Trust, Q4 2025 Earnings, 2026 Guidance, Commercial Paper Program, Asset Dispositions, Debt Reduction, Same Store NOI, FFO, Healthcare Real Estate, Corporate Governance, Credit Rating